NEW YORK (GenomeWeb News) – The Australian fluorescence products developer Fluorotechnics has purchased The Gel Company for an undisclosed sum.
The San Francisco-based GelCo provides a variety of products for applications in DNA sequencing, proteomics, cell culture, liquid handling, microarray, and PCR.
Fluorotechnics said the GelCo product suite allows its non-fluorescent backed gels to “operate on most equipment platforms used in the typical proteomics workflow.” In addition, GelCo’s distribution office in San Francisco will give Fluorotechnics a “very useful launch pad for the US Market,” Fluorotechnics CEO Duncan Veal said in a statement.